Nexus AG: VERY STRONG SALES AND EARNINGS INCREASE IN THE THIRD QUARTER 2022

Donaueschingen (pta008/08.11.2022/08:52 UTC+1)

08/11/2022: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by 10% and EBIT by approx. 24% in the first nine months of 2022. As a result, the continually positive development of sales and earnings of the last years could be continued.

Sales improved from KEUR 137,223 to KEUR 150,790 (+9.9%) in the first nine months 2022. The international share of total business volume was 47.5% (9M-2021: 46.1%) and amounted to KEUR 71,551 compared to KEUR 63,268 (9M-2021).

The consolidated surplus rose very sharply by 24.6% to KEUR 13,845 (9M-2021: KEUR 11,110), and consolidated earnings before interest and taxes (EBIT) rose by 24.1% to KEUR 18,794 (9M-2021: KEUR 15,140): EBITA increased by 19.9% from KEUR 18,639 (9M-2021) to KEUR 22,351, and EBITDA increased by 13.2% to KEUR 31,236 (9M-2021 KEUR 27,605).

Cash flow from operating activities amounted to KEUR 30,948 (9M 2021: KEUR 24,727) in the first nine months of the year 2022, which is 25.2 % higher than in the previous year.

As of 30/09/2022, the company had cash resources at its disposal in the amount of KEUR 109,783 (31/12/2021: KEUR 26,172). Nexus AG had equity capital amounting to KEUR 234,931 as of 30/09/2022 (31/12/2021: KEUR 142,403). Consequently, the equity capital rate is 70.4% (31/12/2021: 57.6%).

NEXUS AG

Managing Board

(end)

Emitter:	Nexus AG Irmastraße 1 78166 Donaueschingen Germany
Contact Person:	Hannes Wehinger
Phone:	+49 771 22960-260
E-Mail:	ir@nexus-ag.de
Website:	www.nexus-ag.de
ISIN(s):	DE0005220909 (Share)
Stock Exchange(s):	Regulated Market in Frankfurt, Hamburg; Free Market in Berlin, Dusseldorf, Munich, Stuttgart